Primary aldosteronism: From bench to bedside

Endocrine

Volumn 41, Issue 1, 2012, Pages 31-39

  Sukor, Norlela ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Adrenal venous sampling; Aldosterone renin ratio; Bilateral adrenal hyperplasia; Familial hyperaldosteronism; Primary aldosteronism

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBON 11; CORTICOTROPIN; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; METOMIDATE; MINERALOCORTICOID ANTAGONIST; POTASSIUM; RENIN; SPIRONOLACTONE;

ADRENAL INCIDENTALOMA; ADRENALECTOMY; ALDOSTERONE BLOOD LEVEL; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIET SUPPLEMENTATION; DISEASE DURATION; ENDOCRINE FUNCTION TEST; ERECTILE DYSFUNCTION; FAMILIAL DISEASE; FAMILIAL HYPERALDOSTERONISM TYPE 1; FAMILIAL HYPERALDOSTERONISM TYPE 2; FAMILIAL HYPERALDOSTERONISM TYPE 3; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC SCREENING; GYNECOMASTIA; HUMAN; HYPERTENSION; HYPOKALEMIA; LIBIDO DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROVOCATION TEST; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT LOADING; SENSITIVITY AND SPECIFICITY; SLEEP APNEA SYNDROME;

EID: 84862669861     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9553-3     Document Type: Review

References (87)

1. S.A. Simpson, J.F. Tait, A. Wettstein, R. Neher, J. Von Euw, O. Schindler, T. Reichstein, Constitution of aldosterone, a new mineralocorticoid. Experientia 10, 132-133 (1954)
2. J.W. Conn, The evolution of primary aldosteronism: 1954-1967. Harvey Lect. 62, 257-291 (1966)
3. P. Milliez, X. Girerd, P.F. Plouin, J. Blacher, M.E. Safar, J.J. Mourad, Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol. 45, 1243-1248 (2005) (Pubitemid 40523144)
4. M. Stowasser, J. Sharman, R. Leano, R.D. Gordon, G. Ward, D. Cowley, T.H. Marwick, Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J. Clin. Endocrinol. Metab. 90, 5070-5076 (2005) (Pubitemid 41262256)
5. C. Catena, G. Colussi, E. Nadalini, A. Chiuch, S. Baroselli, R. Lapenna, L.A. Sechi, Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch. Intern. Med. 168, 80-85 (2008)
6. D.J. Sutherland, J.L. Ruse, J.C. Laidlaw, Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can. Med. Assoc. J. 95, 1109-1119 (1966)
7. R.P. Lifton, R.G. Dluhy, M. Powers, G.M. Rich, S. Cook, S. Ulick, J.M. Lalouel, A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355, 262-265 (1992)
8. J.R. Jonsson, S.A. Klemm, T.J. Tunny, M. Stowasser, R.D. Gordon, A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem. Biophys. Res. Commun. 207, 565-571 (1995)
9. R.D. Gordon, M. Stowasser, T.J. Tunny, S.A. Klemm, W.L. Finn, A.L. Krek, Clinical and pathological diversity of primary aldosteronism, including a new familial variety. Clin. Exp. Pharmacol. Physiol. 18, 283-286 (1991)
10. Jeskey Y, So A, Gordon RD, Duffy D, Kelemen L, Bulmer B, Stowasser M, Genetic Basis of familial hyperaldosteronism type II: further evidence of linkage at chromosome 7p22. In: Hypertension. 28th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Brisbane, Australia, 49, 1477 (2007)
11. N. Sukor, P. Mulatero, R.D. Gordon, A. So, D. Duffy, C. Bertello, L. Kelemen, Y. Jeske, F. Veglio, M. Stowasser, Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J. Hypertens. 26, 1577-1582 (2008)
12. Y.W. Jeske, A. So, L. Kelemen, N. Sukor, C. Willys, B. Bulmer, R.D. Gordon, D. Duffy, M. Stowasser, Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II. Clin. Exp. Pharmacol. Physiol. 35, 380-385 (2008) (Pubitemid 351337333)
13. So A. Jeske YW, Kelemen L, Bulmer B, Gordon RD, Duffy D, Stowasser M, Examination of candidate genes at chromosome 7p22 in familial hyperaldosteronism type II. Hypertension, 49, 1469 (2007)
14. D.S. Geller, J. Zhang, M.V. Wisgerhof, C. Shackleton, M. Kashgarian, R.P. Lifton, A novel form of human Mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J. Clin. Endocrinol. Metab. 93, 3117-3123 (2008)
15. M. Choi, U.I. Scholl, P. Yue, P. Bjorklund, B. Zhao, C. Nelson- Williams, W. Ji, Y. Cho, A. Patel, C.J. Men, E. Lolis, M.V. Wisgerhof, D.S. Geller, S. Mane, P. Hellman, G. Westin, G. Akerstrom, W. Wang, T. Carling, R.P. Lifton, K? channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331, 768-772 (2011)
16. R.D. Gordon, M. Stowasser, T.J. Tunny, S.A. Klemm, J.C. Rutherford, High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin. Exp. Pharmacol. Physiol. 21, 315-318 (1994) (Pubitemid 24201225)
17. P. Mulatero, M. Stowasser, K.C. Loh, C.E. Fardella, R.D. Gordon, L. Mosso, C.E. Gomez-Sanchez, F. Veglio, W. F. Young Jr, Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J. Clin. Endocrinol. Metab. 89, 1045-1050 (2004) (Pubitemid 38368386)
18. G.P. Rossi, G. Bernini, C. Caliumi, G. Desideri, B. Fabris, C. Ferri, C. Ganzaroli, G. Giacchetti, C. Letizia, M. Maccario, F. Mallamaci, M. Mannelli, M.J. Mattarello, A. Moretti, G. Palumbo, G. Parenti, E. Porteri, A. Semplicini, D. Rizzoni, E. Rossi, M. Boscaro, A.C. Pessina, F. Mantero, A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J. Am. Coll. Cardiol. 48, 2293-2300 (2006) (Pubitemid 44873058)
19. L. Mosso, C. Carvajal, A. Gonzalez, A. Barraza, F. Avila, J. Montero, A. Huete, A. Gederlini, C.E. Fardella, Primary aldosteronism and hypertensive disease. Hypertension 42, 161-165 (2003) (Pubitemid 36944590)
20. M.K. Nishizaka, M. Pratt-Ubunama, M.A. Zaman, S. Cofield, D.A. Calhoun, Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension. Am. J. Hypertens. 18, 805-812 (2005) (Pubitemid 40745266)
21. G.E. Umpierrez, P. Cantey, D. Smiley, A. Palacio, D. Temponi, K. Luster, A. Chapman, Primary aldosteronism in diabetic subjects with resistant hypertension. Diabetes Care 30, 1699-1703 (2007) (Pubitemid 47036339)
22. G. Bernini, A. Moretti, G. Argenio, A. Salvetti, Primary aldosteronism in normokalemic patients with adrenal incidentalomas. Eur. J. Endocrinol. 146, 523-529 (2002) (Pubitemid 34436465)
23. D.A. Calhoun, M.K. Nishizaka, M.A. Zaman, R.B. Thakkar, P. Weissmann, Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40, 892-896 (2002) (Pubitemid 35434912)
24. A. Di Murro, L. Petramala, D. Cotesta, L. Zinnamosca, E. Crescenzi, C. Marinelli, M. Saponara, C. Letizia, Reninangiotensin- aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 11, 165-172 (2010)
25. R.D. Gordon, M. Stowasser, Primary aldosteronism: the case for screening. Nat Clin Pract Nephrol 3, 582-583 (2007) (Pubitemid 350012823)
26. D.A. Calhoun, Is there an unrecognized epidemic of primary aldosteronism? (Pro). Hypertension 50, 447-453 (2007). discussion 447-53
27. N.M. Kaplan, Is there an unrecognized epidemic of primary aldosteronism? (Con). Hypertension 50, 454-458 (2007). discussion 454-8
28. J.W. Funder, R.M. Carey, C. Fardella, C.E. Gomez-Sanchez, F. Mantero, M. Stowasser, W. F. Young Jr., V.M. Montori, Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 3266-3281 (2008)
29. M. Stowasser, R.D. Gordon, J.C. Rutherford, N.Z. Nikwan, N. Daunt, G.J. Slater, Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2, 156-169 (2001) (Pubitemid 33685887)
30. R.D. Gordon, Primary aldosteronism. J. Endocrinol. Invest. 18, 495-511 (1995)
31. P. Mulatero, F. Rabbia, A. Milan, C. Paglieri, F. Morello, L. Chiandussi, F. Veglio, Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 40, 897-902 (2002) (Pubitemid 35434913)
32. M. Stowasser, R.D. Gordon, Primary aldosteronism-careful investigation is essential and rewarding. Mol. Cell. Endocrinol. 217, 33-39 (2004) (Pubitemid 38596626)
33. D.J. Campbell, J. Nussberger, M. Stowasser, A.H. Danser, A. Morganti, E. Frandsen, J. Menard, Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement. Clin. Chem. 55, 867-877 (2009)
34. A.H. Ahmed, R.D. Gordon, P.J. Taylor, G. Ward, E. Pimenta, M. Stowasser, Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration. J J Clin Endocrinol Metab 96, 1797-1804 (2011)
35. F.H. Derkx, C. Steunkel, M.P. Schalekamp, W. Visser, I.H. Huisveld, M.A. Schalekamp, Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives. J. Clin. Endocrinol. Metab. 63, 1008-1015 (1986) (Pubitemid 16004310)
36. S.Z. Goldhaber, C.H. Hennekens, R.F. Spark, D.A. Evans, B. Rosner, J.O. Taylor, E.H. Kass, Plasma renin substrate, renin activity, and aldosterone levels in a sample of oral contraceptive users from a community survey. Am. Heart J. 107, 119-122 (1984) (Pubitemid 14219176)
37. A.H. Ahmed, M. Calvird, R.D. Gordon, P.J. Taylor, G. Ward, E. Pimenta, R. Young, M. Stowasser, Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone/renin ratio in normotensive depressed male patients. J. Clin. Endocrinol. Metab. 96, 1039-1045 (2011)
38. M. Stowasser, R.D. Gordon, Primary aldosteronism. Best Pract Res Clin Endocrinol Metab 17, 591-605 (2003)
39. E. Letavernier, S. Peyrard, L. Amar, F. Zinzindohoue, B. Fiquet, P.F. Plouin, Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J. Hypertens. 26, 1816-1823 (2008)
40. K.C. Loh, E.S. Koay, M.C. Khaw, S.C. Emmanuel, W. F. Young Jr, Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J. Clin. Endocrinol. Metab. 85, 2854-2859 (2000) (Pubitemid 32269163)
41. G.P. Rossi, T.M. Seccia, A.C. Pessina, Primary aldosteronism- part I: prevalence, screening, and selection of cases for adrenal vein sampling. J Nephrol 21, 447-454 (2008)
42. W.F.J. Young, Primary aldosteronism: update on diagnosis and treatment. Endocrinologist 7, 213-221 (1997)
43. P. Mulatero, C. Bertello, C. Garrone, D. Rossato, G. Mengozzi, A. Verhovez, F. Fallo, F. Veglio, Captopril test can give misleading results in patients with suspect primary aldosteronism. Hypertension 50, e26-e27 (2007) (Pubitemid 47205812)
44. G.P. Rossi, A. Belfiore, G. Bernini, G. Desideri, B. Fabris, C. Ferri, G. Giacchetti, C. Letizia, M. Maccario, F. Mallamaci, M. Mannelli, G. Palumbo, D. Rizzoni, E. Rossi, E. Agabiti-Rosei, A.C. Pessina, F. Mantero, Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50, 424-431 (2007) (Pubitemid 47205795)
45. M. Stowasser, Update in primary aldosteronism. J. Clin. Endocrinol. Metab. 94, 3623-3630 (2009)
46. F.E. Nwariaku, B.S. Miller, R. Auchus, S. Holt, L. Watumull, B. Dolmatch, S. Nesbitt, W. Vongpatanasin, R. Victor, F. Wians, E. Livingston, W. H. Snyder 3rd, Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch. Surg. 141, 497-502 (2006). discussion 502-3
47. W.F. Young, A.W. Stanson, G.B. Thompson, C.S. Grant, D.R. Farley, J.A. van Heerden, Role for adrenal venous sampling in primary aldosteronism. Surgery 136, 1227-1235 (2004) (Pubitemid 39647538)
48. T. Nishikawa, M. Omura, Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed. Pharmacother. 54(Suppl 1), 83s-85s (2000) (Pubitemid 30428896)
49. M. Omura, H. Sasano, T. Fujiwara, K. Yamaguchi, T. Nishikawa, Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metabolism 51, 350-355 (2002) (Pubitemid 34232637)
50. M.J. Kempers, J.W. Lenders, L. van Outheusden, G.J. van der Wilt, L.J. Schultze Kool, A.R. Hermus, J. Deinum, Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann. Intern. Med. 151, 329-337 (2009)
51. G.P. Rossi, A. Sacchetto, M. Chiesura-Corona, R. De Toni, M. Gallina, G.P. Feltrin, A.C. Pessina, Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J. Clin. Endocrinol. Metab. 86, 1083-1090 (2001) (Pubitemid 32322986)
52. C. Plank, F. Wolf, H. Langenberger, C. Loewe, M. Schoder and J. Lammer, Adrenal venous sampling using Dyna-CT-A practical guide. Eur J Radiol (2011)
53. G.P. Rossi, C. Ganzaroli, D. Miotto, R. De Toni, G. Palumbo, G.P. Feltrin, F. Mantero, A.C. Pessina, Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J. Hypertens. 24, 371-379 (2006) (Pubitemid 43348251)
54. T.M. Seccia, D. Miotto, R. De Toni, G. Pitter, F. Mantero, A.C. Pessina, G.P. Rossi, Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols. Hypertension 53, 761-766 (2009)
55. J. Hennings, A. Sundin, A. Hagg, P. Hellman, 11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism. Langenbecks Arch Surg 395, 963-967 (2010)
56. W. F. Young Jr, Minireview: primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology 144, 2208-2213 (2003) (Pubitemid 36629868)
57. L.A. Sechi, G. Colussi, A. Di Fabio, C. Catena, Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment. Am. J. Hypertens. 23, 1253-1260 (2010)
58. A.H. Ahmed, R.D. Gordon, N. Sukor, E. Pimenta, M. Stowasser, Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically. J. Clin. Endocrinol. Metab. 96, 2904-2911 (2011)
59. N. Sukor, C. Kogovsek, R.D. Gordon, D. Robson, M. Stowasser, Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. J. Clin. Endocrinol. Metab. 95, 1360-1364 (2010)
60. N. Sonino, E. Tomba, M.L. Genesia, C. Bertello, P. Mulatero, F. Veglio, G.A. Fava, F. Fallo, Psychological assessment of primary aldosteronism: a controlled study. J. Clin. Endocrinol. Metab. 96, E878-E883 (2011)
61. J.C. Rutherford, W.L. Taylor, M. Stowasser, R.D. Gordon, Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production. World J. Surg. 22, 1243-1245 (1998) (Pubitemid 28514344)
62. M. Stowasser, S.A. Klemm, T.J. Tunny, W.J. Storie, J.C. Rutherford, R.D. Gordon, Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness. Clin. Exp. Pharmacol. Physiol. 21, 319-322 (1994) (Pubitemid 24201226)
63. N.E. Jacobsen, J.B. Campbell, M.G. Hobart, Laparoscopic versus open adrenalectomy for surgical adrenal disease. Can J Urol 10, 1995-1999 (2003)
64. H. Rossi, A. Kim, R.A. Prinz, Primary hyperaldosteronism in the era of laparoscopic adrenalectomy. Am. Surg. 68, 253-256 (2002). discussion 256-7 (Pubitemid 44943186)
65. J.C. Rutherford, M. Stowasser, T.J. Tunny, S.A. Klemm, R.D. Gordon, Laparoscopic adrenalectomy. World J. Surg. 20, 758-760 (1996). discussion 761
66. J.J. Brown, D.L. Davies, J.B. Ferriss, R. Fraser, E. Haywood, A.F. Lever, J.I. Robertson, Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin. Br. Med. J. 2, 729-734 (1972)
67. J.Y. Pagny, G. Chatellier, J.M. Duclos, P.F. Plouin, P. Corvol, J. Menard, Results of the surgical treatment of Conn's adenomas. Archives des Maladies du Coeur et des Vaisseaux 80, 995-998 (1987) (Pubitemid 17144862)
68. C.A. Proye, E.A. Mulliez, B.M. Carnaille, M. Lecomte-Houcke, M. Decoulx, J.L. Wemeau, J. Lefebvre, A. Racadot, O. Ernst, D. Huglo, A. Carre, Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism? Surgery 124, 1128-1133 (1998) (Pubitemid 28555205)
69. Y. Horita, T. Inenaga, H. Nakahama, H. Ishibashi-Ueda, Y. Kawano, S. Nakamura, T. Horio, N. Okuda, M. Ando, S. Takishita, Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism. Am. J. Kidney Dis. 37, 884-889 (2001) (Pubitemid 32471846)
70. Y. Fukudome, K. Fujii, H. Arima, Y. Ohya, T. Tsuchihashi, I. Abe, M. Fujishima, Discriminating factors for recurrent hypertension in patients with primary aldosteronism after adrenalectomy. Hypertens. Res. 25, 11-18 (2002) (Pubitemid 34196290)
71. T. Obara, Y. Ito, T. Okamoto, Y. Kanaji, T. Yamashita, M. Aiba, Y. Fujimoto, Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Surgery 112, 987-993 (1992) (Pubitemid 23008223)
72. G. Favia, F. Lumachi, V. Scarpa, D.F. D'Amico, Adrenalectomy in primary aldosteronism: a long-term follow-up study in 52 patients. World J. Surg. 16, 680-683 (1992). discussion 683-4
73. P. Sapienza, A. Cavallaro, Persistent hypertension after removal of adrenal tumours. Eur. J. Surg. 165, 187-192 (1999) (Pubitemid 29374444)
74. C.Y. Lo, P.C. Tam, A.W. Kung, K.S. Lam, J. Wong, Primary aldosteronism. Results of surgical treatment. Ann. Surg. 224, 125-130 (1996) (Pubitemid 26272057)
75. R.J. Weigel, S.A. Wells, J.C. Gunnells, G.S. Leight, Surgical treatment of primary hyperaldosteronism. Ann. Surg. 219, 347-352 (1994) (Pubitemid 24121447)
76. A.M. Sawka, W.F. Young, G.B. Thompson, C.S. Grant, D.R. Farley, C. Leibson, J.A. van Heerden, Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann. Intern. Med. 135, 258-261 (2001) (Pubitemid 32799339)
77. X. Jeunemaitre, G. Chatellier, C. Kreft-Jais, A. Charru, C. DeVries, P.F. Plouin, P. Corvol, J. Menard, Efficacy and tolerance of spironolactone in essential hypertension. Am. J. Cardiol. 60, 820-825 (1987) (Pubitemid 17163442)
78. M.H. Weinberger, B. Roniker, S.L. Krause, R.J. Weiss, Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. Am. J. Hypertens. 15, 709-716 (2002) (Pubitemid 34804277)
79. M. de Gasparo, U. Joss, H.P. Ramjoue, S.E. Whitebread, H. Haenni, L. Schenkel, C. Kraehenbuehl, M. Biollaz, J. Grob, J. Schmidlin et al., Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro. J. Pharmacol. Exp. Ther. 240, 650-656 (1987) (Pubitemid 17018455)
80. A. Karagiannis, K. Tziomalos, A. Papageorgiou, A.I. Kakafika, E.D. Pagourelias, P. Anagnostis, V.G. Athyros, D.P. Mikhailidis, Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert Opin Pharmacother 9, 509-515 (2008) (Pubitemid 351425379)
81. H.K. Parthasarathy, J. Menard, W.B. White, W. F. Young Jr., G.H. Williams, B. Williams, L.M. Ruilope, G.T. McInnes, J.M. Connell, T.M. MacDonald, A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. J. Hypertens. 29, 980-990 (2011)
82. G.T. Griffing, A.G. Cole, S.A. Aurecchia, B.H. Sindler, P. Komanicky, J.C. Melby, Amiloride in primary hyperaldosteronism. Clin. Pharmacol. Ther. 31, 56-61 (1982) (Pubitemid 12135809)
83. G.T. Griffing, J.C. Melby, The therapeutic use of a new potassium- sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism. Clin Exp Hypertens A Theory Practice 5, 779-801 (1983) (Pubitemid 13026500)
84. F. Mantero, F. Fallo, G. Opocher, D. Armanini, M. Boscaro, C. Scaroni, Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. Clin Sci (London) 61(Suppl 7), 289s-293s (1981) (Pubitemid 12222752)
85. S. Zacharieva, I. Atanassova, E. Natchev, M. Orbetzova, D. Tzingilev, Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension. Methods Find. Exp. Clin. Pharmacol. 23, 153-156 (2001) (Pubitemid 32720614)
86. M.J. Brown, R.V. Hopper, Calcium-channel blockade can mask the diagnosis of Conn's syndrome. Postgrad. Med. J. 75, 235-236 (1999) (Pubitemid 29145871)
87. P. Mulatero, C. Bertello, N. Sukor, R. Gordon, D. Rossato, N. Daunt, D. Leggett, G. Mengozzi, F. Veglio, M. Stowasser, Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension 55, 667-673 (2010)